Inroads in the therapy of indolent lymphomas: exploiting biological insights

MeSH terms

• Antibodies, Monoclonal / therapeutic use
• Antibodies, Neoplasm / therapeutic use
• Antimetabolites, Antineoplastic / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Apoptosis
• Biomarkers, Tumor / analysis
• Case Management
• Clinical Trials as Topic
• Genes, bcl-2
• Humans
• Immunologic Factors
• Interferon-alpha / therapeutic use
• Iodine Radioisotopes / therapeutic use
• Lymphatic Irradiation
• Lymphoma, Non-Hodgkin / classification
• Lymphoma, Non-Hodgkin / genetics
• Lymphoma, Non-Hodgkin / mortality
• Lymphoma, Non-Hodgkin / pathology
• Lymphoma, Non-Hodgkin / therapy*
• Polymerase Chain Reaction
• Prognosis
• Proto-Oncogene Proteins c-bcl-2 / physiology
• Radioimmunotherapy
• Remission Induction
• Survival Analysis
• Translocation, Genetic